Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization | Zendy

Victor E. Mulanovich | Zendy; Michael D. Huband | Zendy; Sandra P. McCurdy | Zendy; M. Megan Lemmon | Zendy; Marykay Lescoe | Zendy; Ying Jiang | Zendy; K. V. I. Rolston | Zendy; P. Rocco LaSala | Zendy

Open Access

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization

Author(s) -

Victor E. Mulanovich,

Michael D. Huband,

Sandra P. McCurdy,

M. Megan Lemmon,

Marykay Lescoe,

Ying Jiang,

K. V. I. Rolston,

P. Rocco LaSala

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq238

Subject(s) - linezolid , cons , medicine , staphylococcus aureus , coagulase , staphylococcus , outbreak , cancer , methicillin resistant staphylococcus aureus , microbiology and biotechnology , biology , vancomycin , virology , bacteria , genetics , computer science , programming language

The prevalence of linezolid-resistant coagulase-negative Staphylococcus (CoNS) in the MD Anderson Cancer Center rose from 0.6% in 2007 to 5.5% in 2009. The aim of our study was to analyse the relationship between linezolid use and an outbreak of linezolid-resistant CoNS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research